[ad_1]
Stephens reaffirmed an “overweight” rating and issued a $6.00 target price on shares of C4 Therapeutics in a research report on Monday.
[ad_2]
Source link
Related Posts
Jack Bendheim Sells 7,022 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock
[ad_1] Phibro Animal Health Corporation (NASDAQ:PAHC – Get Free Report) CEO Jack Bendheim sold 7,022 shares of the stock in…
EBAY, TSCO, TJX Beating Tariffs With Strong Stock Gains
[ad_1] American importers are facing the highest average tariff rates in nearly 100 years following President Trump’s India tariff bump,…
Promising Streaming Stocks To Watch Today – August 9th
[ad_1] NVIDIA, Trade Desk, AppLovin, Spotify Technology, and Take-Two Interactive Software are the five Streaming stocks to watch today, according…